Patient satisfaction with extended release tolterodine or oxybutynin in overactive bladder

By Bolge Susan C.   McDonnell Diana D.   Chen Andrew   Wan George J.  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1903-1912

Informa Healthcare

Access to resources Recommend Favorite

Effects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms*

By Herschorn Sender   Heesakkers John   Castro-Diaz David   Wang Joseph T.   Brodsky Marina   Guan Zhonghong  

Current Medical Research and Opinion, Vol. 24, Iss. 12, 2008-12 ,pp. : 3513-3521

Informa Healthcare

Access to resources Recommend Favorite

Propiverine Hydrochloride Immediate and Extended Release: Comparison of Efficacy and Tolerability in Patients with Overactive Bladder

By  

Urologia Internationalis, Vol. 77, Iss. 4, 2006-11 ,pp. : 334-339

Karger

Access to resources Recommend Favorite

Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER

By Zinner Norman   Noe Les   Rasouliyan Lawrence   Marshall Thomas   Seifeldin Raafat  

Current Medical Research and Opinion, Vol. 24, Iss. 6, 2008-06 ,pp. : 1583-1591

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of solifenacin in patients with severe symptoms of overactive bladder: a pooled analysis

By Millard R. J.   Halaska M.  

Current Medical Research and Opinion, Vol. 22, Iss. 1, 2006-01 ,pp. : 41-48

Informa Healthcare

Access to resources Recommend Favorite